October 7, 2008 – CeloNova BioSciences Inc. will showcase the technology behind the CATANIA Coronary Stent System featuring a NanoThin Polyzene-F surface treatment at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium sponsored Oct. 12-17.
The CATANIA Coronary Stent System carries a CE Mark and is currently available for sale outside the U.S.